⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

Sun Pharmaceutical Industries, Inc.: Aisling DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL

DrugsSource: FDA (press release) · Date: 2026-05-13

Read the official notice at FDA (press release) →

Share on XFacebookRedditEmail

Get alerts for Sun Pharmaceutical Industries

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (press release) record. If anything differs, the official notice is correct.

Company / brand
Sun Pharmaceutical Industries, Inc.
Product
DOXOrubicin Hydrochloride Liposome Injection 50mg/25 mL
Reason / hazard
Presence of glass particles
Product type
Drugs,
Brand name
Aisling
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.